Dr Reddy's Laboratories
(NYSE:RDY)
$75.49
0[0.00%]
At close: Mar 18
$75.49
0[0.00%]
PreMarket: 4:16PM EDT

GET A REPORT ON RDY SENT RIGHT TO YOUR INBOX

Dr Reddy's Laboratories Stock (NYSE:RDY), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Overweight
Highest Price Target1
$80.00
Lowest Price Target1
$80.00
Consensus Price Target1
$80.00

Analyst Rating Summary1

Analyst Ratings
Jan
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barclays

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Dr Reddy's Laboratories

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
01/29/2024RDYBuy Now
Dr Reddy's Laboratories
$75.495.97%Barclays
Balaji Prasad
$75 → $80MaintainsOverweightGet Alert
06/01/2023RDYBuy Now
Dr Reddy's Laboratories
$75.49-7.27%Barclays
Balaji Prasad
$67 → $70MaintainsOverweightGet Alert
10/31/2022RDYBuy Now
Dr Reddy's Laboratories
$75.49-11.25%Barclays
Balaji Prasad
$66 → $67MaintainsOverweightGet Alert
10/25/2022RDYBuy Now
Dr Reddy's Laboratories
$75.49-12.57%Barclays
Balaji Prasad
$69 → $66MaintainsOverweightGet Alert
09/12/2022RDYBuy Now
Dr Reddy's Laboratories
$75.49-8.6%Barclays
Balaji Prasad
$68 → $69MaintainsOverweightGet Alert
07/25/2022RDYBuy Now
Dr Reddy's Laboratories
$75.49-9.92%Barclays
Balaji Prasad
$70 → $68MaintainsOverweightGet Alert
05/24/2022RDYBuy Now
Dr Reddy's Laboratories
$75.49-7.27%Barclays
Balaji Prasad
$69 → $70MaintainsOverweightGet Alert
11/01/2021RDYBuy Now
Dr Reddy's Laboratories
$75.495.97%Barclays
Balaji Prasad
MaintainsOverweightGet Alert

FAQ

Q

What is the target price for Dr Reddy's Laboratories (RDY)?

A

The latest price target for Dr Reddy's Laboratories (NYSE: RDY) was reported by Barclays on January 29, 2024. The analyst firm set a price target for $80.00 expecting RDY to rise to within 12 months (a possible 5.97% upside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Dr Reddy's Laboratories (RDY)?

A

The latest analyst rating for Dr Reddy's Laboratories (NYSE: RDY) was provided by Barclays, and Dr Reddy's Laboratories maintained their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Dr Reddy's Laboratories (RDY)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dr Reddy's Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dr Reddy's Laboratories was filed on January 29, 2024 so you should expect the next rating to be made available sometime around January 29, 2025.

Q

Is the Analyst Rating Dr Reddy's Laboratories (RDY) correct?

A

While ratings are subjective and will change, the latest Dr Reddy's Laboratories (RDY) rating was a maintained with a price target of $75.00 to $80.00. The current price Dr Reddy's Laboratories (RDY) is trading at is $75.49, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch